Emerging Issues and Trends in Attention Deficit Hyperactivity Disorder: An Update for the Speech-Language Pathologist

There are many trends in the diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) that have emerged over the past several years. The first of these emerging trends is the growing prevalence of ADHD diagnoses across age groups and cultures. Although the causes of this growing prevalence are unclear, several suggestions, including a broader definition of ADHD, are discussed as potential contributions. A second emerging issue is related to the underlying theory of ADHD. Barkley's biopsychosocial model of ADHD is briefly discussed as a prototype model to help in the understanding of ADHD. Finally, the growing trend in pharmacological treatment of ADHD is discussed. Stimulant medications, as well as a recent nonstimulant medication are discussed and compared with nonpharmacological alternatives.

ADHD - trends - medication - theory

REFERENCES

• 1 Augustine L, Damico J S. Attention deficit hyperactivity disorder: the scope of the problem.  Semin Speech Lang. 1995;  16 243-258
• 2 Volkmar F R. Changing perspectives on ADHD.  Am J Psychiatry. 2003;  160 1025-1027
• 3 Lord J, Paisley S. The Clinical Effectiveness and Cost Effectiveness of Methylphenidate for Hyperactivity in Childhood, Version 2. London; National Institute for Clinical Excellence 2000
• 4 Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children.  Child Adolesc Psychiatr Clin N Am. 2000;  9 541-555
• 5 Clegg J, Hartshorne M. Speech and language therapy in hyperactivity: a United Kingdom perspective in complex cases.  Semin Speech Lang. 2004;  25 263-270
• 6 Swanson J M, Sergeant J A, Taylor E et al.. Attention-deficit hyperactivity disorder and hyperkinetic disorder.  Lancet. 1998;  351 429-433
• 7 Taylor E, Sergeant J, Doepfner M et al.. Clinical guidelines for hyperkinetic disorder.  Eur Child Adolesc Psychiatry. 1998;  7 184-200
• 8 Jouglin C, Zwi M. FOCUS on the Use of Stimulants in Children With ADHD. Primary Evidence-Base Briefing No 1. Focus Project London; Royal College of Psychiatrists' Research Unit 1999
• 9 World Health Organization .International Classification of Diseases. New York; World Health Organization Publications 2002
• 10 British Psychological Society .Attention Deficit Hyperactivity Disorder (ADHD): a Psychological Response to an Evolving Concept. Leicester, England; The British Psychological Society 1996
• 11 American Speech-Language-Hearing Association .Technical Report on the Roles of Audiologists and Speech-Language Pathologists Working With Students With Attention Deficit Hyperactivity Disorder. Rockville, MD; ASHA 1996
• 12 American Academy of Child and Adolescent Psychiatry . Practice parameters for the assessment and treatment of children, adolescents and adults with ADHD.  J Am Acad Child Adolesc Psychiatry. 1997;  36 85S-121S
• 13 American Academy of Pediatrics . Clinical practice guideline-treatment of the child with attention deficit/hyperactivity disorder (AC0002).  Pediatrics. 2000;  108 1033-1044
• 14 Brock S E. Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) in Childhood: a Review of the Literature. (ERIC Document Reproduction Service No. ED 410512) Anaheim, CA; National Association of School Psychologists 1997
• 15 National Institutes of Health . Consensus statement: diagnosis and treatment of attention deficit hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry. 2000;  39 182-193
• 16 Greydanus D E. Psychopharmacology for ADHD in adolescents: quo vadis?.  Psychiat Times. 2003;  44 48-55
• 17 Ingram S, Hechman I, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-term outcome.  Ment Retard Dev Disord Res Rev. 1999;  5 243-250
• 18 Mannuzza S, Klein R G, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up.  Am J Psychiatry. 1998;  155 493-498
• 19 Boyajian A E, DuPaul G J, Handler M W, Eckert T L, McGoey K E. The use of classroom-based behavior functional analyses with preschoolers at risk for attention deficit hyperactivity disorder.  School Psychol Rev. 2001;  30 278-293
• 20 Connor D F. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.  J Dev Behav Pediatr. 2002;  23(Suppl I) S1-S9
• 21 Loughran S B. Agreement and stability of teacher rating scales for assessing ADHD in preschoolers.  Early Child Ed J. 2003;  30 247-253
• 22 Armstrong M B, Nettleton S. Attention deficit/hyperactivity disorder and preschool children.  Semin Speech Lang. 2004;  25 225-232
• 23 Pierce C D, Reid R. Attention deficit hyperactivity disorder: assessment and treament of children from culturally different groups.  Semin Speech Lang. 2004;  25 233-240
• 24 Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry. 1997;  36(Suppl 10) 85S-121S
• 25 Jerrell J M. Are assessment and treatment influenced by ethnicity and gender?.  Psychiat Times. 2003;  44 71-74
• 26 Ridley C R, Li L C, Hill C L. Multicultural assessment: reexamination, reconceptualization, and practical application.  Couns Psychol. 1998;  26 827-910
• 27 Damico J S, Muller N, Ball M J. Owning up to complexity: a sociocultural orientation to attention deficit hyperactivity disorder.  Semin Speech Lang. 2004;  25 277-284
• 28 Barkley R A. ADHD and the Nature of Self-Control. New York; Guilford Press 1997
• 29 Barkley R A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.  Psychol Bull. 1997;  121 65-94
• 30 Damico J S, Damico S K, Armstrong M B. Attention-deficit hyperactivity disorder and communicative disorders.  Child Adol Psych Clinics N Am. 1999;  8 37-60
• 31 Westby C E, Cutler S K. Language and ADHD: understanding the bases and treatment of self-regulatory deficits.  Top Lang Disord. 1994;  14 58-76
• 32 Westby C, Watson S. Perspectives on attention deficit hyperactivity disorder: executive functions, working memory, and language disabilities.  Semin Speech Lang. 2004;  25 241-254
• 33 Dunaway C. Attention deficit hyperactivity disorder: an authentic story in the schools and its implications.  Semin Speech Lang. 2004;  25 271-276
• 34 Nelson R, Hawley H. Inner control as an operational mechanism in attention deficit hyperactivity disorder.  Semin Speech Lang. 2004;  25 255-262
• 35 Greenhill L L, Halperin J M, Abikoff H. Stimulant medications.  J Am Acad Child Adolesc Psychiatry. 1999;  35 503-512
• 36 Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder. Safety, efficacy, and long-term outcome.  Pediatr Drugs. 2003;  5 787-794
• 37 Kollins S H, Barkley R A, DuPaul G J. Use and management of medications for children diagnosed with attention deficit/hyperactivity disorder (ADHD).  Focus Except Child. 2001;  33 1-24
• 38 Popper C W. Pharmacological alternatives to psychostimulants for the treatment of attention deficit/hyperactivity disorder.  Child Adol Psych Clinics of N Am. 2002;  9 605-646
• 39 Zito J M, Safer D J, dos Reis S et al.. Trends in the prescribing of psychotropic medication to preschoolers.  JAMA. 2000;  283 1025-1030
• 40 Accardo P A, Blondis T A. What's all the fuss about Ritalin?.  J Pediatr. 2001;  138 6-9
• 41 DeBar L L, Lynch F, Powell J, Gale J. Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization.  Arch Pediatr Adolesc Med. 2003;  157 150-157
• 42 McGoey K E, Eckert T L, DuPaul G. Early intervention for preschool-age children with ADHD: a literature review.  J Emot Behav Disord. 2002;  10 14-28
• 43 Rappley M D, Mullen P B, Alvarez F J et al.. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.  Arch Pediatr Adolesc Med. 1999;  153 1039-1045
• 44 Barkley R A. Attention-Deficit Hyperactivity Disorder: a Handbook for Diagnosis and Treatment, 2nd ed. New York; Guilford Press 1998
• 45 Greenhill L L, Pliszka S, Dulcan M K et al.. Practice parameter for the use of stimulant medications in treatment of children, adolescent, and adults.  J Am Acad Child Adolesc Psychiatry. 2002;  41(Suppl 2) 26S-49S
• 46 Greydanus D E, Patel D R. Sports doping in the adolescent athlete: the hope, hype, and hyperbole.  Pediatr Clin North Am. 2002;  49 829-855
• 47 Greydanus D E, Sloane M A, Rappley M D. Psychopharmacology of ADHD in adolescents.  Adolesc Med. 2002;  13 599-624
• 48 Schachter H M, Pham B, King J et al.. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents: a meta-analysis.  Can Med Assoc J. 2001;  165 1475-1488
• 49 Solanto M V, Arnsten A FT, Castellanos F X. The neuroscience of stimulant drug action in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX Stimulant Drugs and ADHD: Basic and Clinical Neuroscience Oxford; Oxford University Press 2001: 355-379
• 50 Eli Lilly and Company .Package insert: Strattera. Indianapolis, IN; Eli Lilly 2002
• 51 MTA Cooperative Group . 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder.  Arch Gen Psychiatry. 1999;  56 1073-1086
• 52 Carey W B. What the multimodal treatment study of children with ADHD did and did not say about the use of methylphenidate for attention deficits.  Pediatrics. 2000;  105 863-864
• 53 Pelham W E. The NIMH multimodal treatment study for attention deficit hyperactivity disorder: just say yes to drugs alone?.  Can J Psychiatry. 1999;  44 981-990
• 54 Tetnowski J A. Attention deficit hyperactivity disorder and concomitant communicative disorders.  Semin Speech Lang. 2004;  25 215-224